The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
出版年份 2023 全文链接
标题
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
作者
关键词
-
出版物
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-25
DOI
10.1007/s40262-023-01312-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Initial Decline ("dip") in Estimated Glomerular Filtration Rate Following Initiation of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF.
- (2022) Carly Adamson et al. CIRCULATION
- Dose–Exposure–Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD
- (2022) Sebastiaan Camiel Goulooze et al. CLINICAL PHARMACOKINETICS
- Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers
- (2022) Roland Heinig et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3
- (2022) Roland Heinig et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- The Nonsteroidal Mineralocorticoid-Receptor-Antagonists Finerenone in Cardiorenal Medicine: A State-of-the-Art Review of the Literature
- (2022) Panagiotis I Georgianos et al. AMERICAN JOURNAL OF HYPERTENSION
- The drug titration paradox: Correlation of more drug with less effect in clinical data
- (2021) Thomas W. Schnider et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Determination of finerenone – a novel, selective, nonsteroidal mineralocorticoid receptor antagonist – in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in venous and capillary human plasma
- (2021) Gabriele Rohde et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A generic framework for the physiologically‐based pharmacokinetic platform qualification of PK‐Sim and its application to predicting cytochrome P450 3A4–mediated drug–drug interactions
- (2021) Sebastian Frechen et al. CPT-Pharmacometrics & Systems Pharmacology
- Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis
- (2021) Paul van den Berg et al. CLINICAL PHARMACOKINETICS
- Finerenone Dose–Exposure–Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria
- (2021) Sebastiaan Camiel Goulooze et al. CLINICAL PHARMACOKINETICS
- Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone
- (2021) Thomas Wendl et al. CPT-Pharmacometrics & Systems Pharmacology
- Results from Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications
- (2020) Roland Heinig et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment
- (2019) Roland Heinig et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole
- (2019) Denise Türk et al. CLINICAL PHARMACOKINETICS
- Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function
- (2019) Hiroki Kobayashi et al. HYPERTENSION
- Population Pharmacokinetic and Exposure–Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease
- (2019) Nelleke Snelder et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo
- (2018) Roland Heinig et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
- (2018) Michael Gerisch et al. DRUG METABOLISM AND DISPOSITION
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies
- (2016) Silvia Lentini et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reliability and Extension of Quantitative Prediction of CYP3A4-Mediated Drug Interactions Based on Clinical Data
- (2014) Constance Loue et al. AAPS Journal
- Consequences of Renal Failure on Non-Renal Clearance of Drugs
- (2014) Laure Lalande et al. CLINICAL PHARMACOKINETICS
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Acute fall in glomerular filtration rate with renin–angiotensin system inhibition: a biomeasure of therapeutic success?
- (2011) Matthew R. Weir KIDNEY INTERNATIONAL
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
- (2008) Roger K. Verbeeck EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started